Table 3 Differences in demographic and clinical characteristics between shoulder disability categories
Characteristic | Level/unit | No–low (n = 206) | Moderate–high (n = 48) | p value | Test |
|---|---|---|---|---|---|
Age at consent | Years | 60.4 (53.2–65.2) | 54.4 (45.0–64.9) | 0.014 | MU |
Time after surgery | Years | 2.9 (1.7–4.5) | 2.6 (1.8–4.3) | 0.728 | MU |
Nodes removed |  | 10.0 (5.0–14.0) | 9.0 (6.0–13.0) | 0.630 | MU |
Side of primary | Left Right | 52 (106) 48 (97) | 54 (26) 46 (22) | 0.873 | F |
Tumor grade | III II I | 23 (41) 53 (96) 24 (44) | 28 (12) 44 (19) 28 (12) | 0.572 | χ2 |
Type of surgery | Mastectomy WLE | 79 (162) 21 (42) | 77 (36) 23 (11) | 0.693 | F |
Lymph node surgery | ALND SLNB | 84 (170) 16 (33) | 79 (37) 21 (10) | 0.398 | F |
Chemotherapy | Yes No | 76 (150) 24 (48) | 81 (39) 19 (9) | 0.567 | F |
Hormonal therapy | Yes No | 78 (151) 22 (43) | 79 (37) 21 (10) | 1.000 | F |
Hormonal regimen | Tamoxifen | 62 (119) | 60 (28) | 0.452 | χ2 |
Aromatase inhibitor | 8 (15) | 4 (2) | |||
Both | 8 (15) | 15 (7) | |||
Radiotherapy | Yes No | 71 (134) 29 (56) | 67 (30) 33 (15) | 0.594 | F |